MedPath
TGA Approval

AFQLIR aflibercept 40 mg/mL solution for intravitreal injection vial with needle (445960)

445960

AFQLIR aflibercept 40 mg/mL solution for intravitreal injection vial with needle

Sandoz Pty Ltd

May 27, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

Aflibercept

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.